Skip to main content
. Author manuscript; available in PMC: 2014 Jul 9.
Published in final edited form as: Biomarkers. 2014 Mar 21;19(3):207–213. doi: 10.3109/1354750X.2014.896414

Table 2.

Mean Annual Rate of Change in Percent Emphysema, by to Baseline Plasma Sphingomyelin Level.

Quintiles of Plasma Sphingomyelin
Q1 Q2 Q3 Q4 Q5 Mean Annual Change in
Percent Emphysema per 1
standard deviation
increase in baseline SM
p-
Value*
Model 1 Ref. 0.003 0.016 0.103 0.247 0.105
(0.015, 0.195)
0.022
Model 2 Ref. 0.031 0.034 0.152 0.263 0.119
(0.020, 0.219)
0.019

Model 1 controlled for age, gender, race, height, weight, BMI, scanner model and protocol.

Model 2 included model 1 variables and further controlled for educational attainment, number of cigarettes smoked per day among current smokers, cumulative pack-years, urinary levels of cotinine at baseline exam, family history of emphysema, having asthma before the age of 45, total serum cholesterol, HDL, LDL, triglycerides, intake of lipid lowering agents, systolic and diastolic and blood pressure, and study field center.

*

P-value for the relationship of mean annual change in percent emphysema to sphingomyelin level expressed as a continuous variable.